Original Research
Accepted on 25 Nov 2025
Limited Utility of Imaging-based (N) Markers in Predicting Cerebral Spinal Fluid Alzheimer's Disease Biomarker Positivity in Lecanemab-Eligible Mild Cognitive Impairment
in Dementia and Neurodegenerative Diseases